Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Metsera
Developing next-gen obesity therapies
Pharma
China signs off on Pfizer, Sciwind's GLP-1 weight loss drug
Pfizer's Sciwind Biosciences-partnered GLP-1 drug has gained approval in China as a treatment for patients with obesity.
Kevin Dunleavy
Mar 6, 2026 11:22am
2025's top biopharma M&A deals
Jan 12, 2026 3:00am
Fierce Biotech
Pfizer finalizes Metsera buy after contentious Novo bidding war
Nov 13, 2025 12:43pm
Fierce Biotech
Pfizer beats out Novo with $10B agreement to buy Metsera
Nov 8, 2025 8:11am
Fierce Biotech
Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera
Nov 7, 2025 10:00am
Fierce Biotech
Judge denies Pfizer’s bid to block Novo’s offer for Metsera
Nov 5, 2025 5:23pm